267 related articles for article (PubMed ID: 21277008)
21. High expression of CD73 as a poor prognostic biomarker in human colorectal cancer.
Wu XR; He XS; Chen YF; Yuan RX; Zeng Y; Lian L; Zou YF; Lan N; Wu XJ; Lan P
J Surg Oncol; 2012 Aug; 106(2):130-7. PubMed ID: 22287455
[TBL] [Abstract][Full Text] [Related]
22. Immunoglobulin kappa and immunoglobulin lambda are required for expression of the anti-apoptotic molecule Bcl-xL in human colorectal cancer tissue.
Yang SB; Chen X; Wu BY; Wang MW; Cai CH; Cho DB; Chong J; Li P; Tang SG; Yang PC
Scand J Gastroenterol; 2009; 44(12):1443-51. PubMed ID: 19883274
[TBL] [Abstract][Full Text] [Related]
23. Increased expression of formin-like 3 contributes to metastasis and poor prognosis in colorectal carcinoma.
Zeng YF; Xiao YS; Lu MZ; Luo XJ; Hu GZ; Deng KY; Wu XM; Xin HB
Exp Mol Pathol; 2015 Apr; 98(2):260-7. PubMed ID: 25758200
[TBL] [Abstract][Full Text] [Related]
24. CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer.
Kawamura M; Toiyama Y; Tanaka K; Saigusa S; Okugawa Y; Hiro J; Uchida K; Mohri Y; Inoue Y; Kusunoki M
Eur J Cancer; 2012 Sep; 48(14):2244-51. PubMed ID: 22197219
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of Bcl-xL in human hepatocellular carcinoma.
Watanabe J; Kushihata F; Honda K; Sugita A; Tateishi N; Mominoki K; Matsuda S; Kobayashi N
Surgery; 2004 Jun; 135(6):604-12. PubMed ID: 15179366
[TBL] [Abstract][Full Text] [Related]
26. Prognostic effects of dihydropyrimidine dehydrogenase in advanced colorectal cancer after surgery: immunohistochemistry using a new monoclonal antibody.
Tokunaga Y; Nakagami M; Tokuka A; Ohsumi K
Anticancer Res; 2003; 23(2C):1763-8. PubMed ID: 12820455
[TBL] [Abstract][Full Text] [Related]
27. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse.
Giatromanolaki A; Sivridis E; Stathopoulos GP; Fountzilas G; Kalofonos HP; Tsamandas A; Vrettou E; Scopa C; Polychronidis A; Simopoulos K; Koukourakis MI
Anticancer Res; 2001; 21(1A):253-9. PubMed ID: 11299743
[TBL] [Abstract][Full Text] [Related]
28. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
[TBL] [Abstract][Full Text] [Related]
29. Predicting lymph node metastasis in early colorectal cancer using the CITED1 expression.
Nasu T; Oku Y; Takifuji K; Hotta T; Yokoyama S; Matsuda K; Tamura K; Ieda J; Yamamoto N; Takemura S; Nakamura Y; Yamaue H
J Surg Res; 2013 Nov; 185(1):136-42. PubMed ID: 23746764
[TBL] [Abstract][Full Text] [Related]
30. Bcl-xL protein: predictor of complete tumor response in patients with oral cancer treated with curative radiotherapy.
Mallick S; Agarwal J; Kannan S; Pawar S; Kane S; Teni T
Head Neck; 2013 Oct; 35(10):1448-53. PubMed ID: 22987535
[TBL] [Abstract][Full Text] [Related]
31. Detection of thymidylate synthase expression in lymph node metastases of colorectal cancer can improve the prognostic information.
Ohrling K; Edler D; Hallström M; Ragnhammar P; Blomgren H
J Clin Oncol; 2005 Aug; 23(24):5628-34. PubMed ID: 16009948
[TBL] [Abstract][Full Text] [Related]
32. Functional and biological analysis of Bcl-xL expression in human osteosarcoma.
Wang ZX; Yang JS; Pan X; Wang JR; Li J; Yin YM; De W
Bone; 2010 Aug; 47(2):445-54. PubMed ID: 20580954
[TBL] [Abstract][Full Text] [Related]
33. Serum levels of bcl-2 in patients with colorectal cancer.
Giannoulis K; Fountzilas G; Angouridakis N; Angouridaki C; Giannoulis E; Gamvros O
Tech Coloproctol; 2004 Nov; 8 Suppl 1():s56-8. PubMed ID: 15655644
[TBL] [Abstract][Full Text] [Related]
34. Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression.
Zlobec I; Baker K; Minoo P; Jass JR; Terracciano L; Lugli A
Clin Cancer Res; 2008 Jan; 14(1):143-8. PubMed ID: 18172264
[TBL] [Abstract][Full Text] [Related]
35. Novel gene hBiot2 is an independent prognostic factor in colorectal cancer patients.
Shen YM; Arbman G; Sandström P; Gullstrand P; Wei YQ; Zhang H; Rosell J; Olsson B; Peng F; Yang HS; Wang CT; Sun XF
Oncol Rep; 2012 Feb; 27(2):376-82. PubMed ID: 22024937
[TBL] [Abstract][Full Text] [Related]
36. MMP13 is a potential prognostic marker for colorectal cancer.
Huang MY; Chang HJ; Chung FY; Yang MJ; Yang YH; Wang JY; Lin SR
Oncol Rep; 2010 Nov; 24(5):1241-7. PubMed ID: 20878116
[TBL] [Abstract][Full Text] [Related]
37. Transforming growth factor-beta1 and regulators of apoptosis.
Sulkowski S; Wincewicz A; Sulkowska M; Koda M
Ann N Y Acad Sci; 2009 Aug; 1171():116-23. PubMed ID: 19723045
[TBL] [Abstract][Full Text] [Related]
38. Clinical significance of UNC5B expression in colorectal cancer.
Okazaki S; Ishikawa T; Iida S; Ishiguro M; Kobayashi H; Higuchi T; Enomoto M; Mogushi K; Mizushima H; Tanaka H; Uetake H; Sugihara K
Int J Oncol; 2012 Jan; 40(1):209-16. PubMed ID: 21922135
[TBL] [Abstract][Full Text] [Related]
39. Quantitative expression of protein markers of plasminogen activation system in prognosis of colorectal cancer.
Seetoo DQ; Crowe PJ; Russell PJ; Yang JL
J Surg Oncol; 2003 Mar; 82(3):184-93. PubMed ID: 12619063
[TBL] [Abstract][Full Text] [Related]
40. Galectin-3 expression is a potent prognostic marker in colorectal cancer.
Endo K; Kohnoe S; Tsujita E; Watanabe A; Nakashima H; Baba H; Maehara Y
Anticancer Res; 2005; 25(4):3117-21. PubMed ID: 16080575
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
